NovaBay Pharmaceuticals Inc
F:B9P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NovaBay Pharmaceuticals Inc
F:B9P
|
US |
|
Tubacex SA
F:TCX
|
ES |
|
Global Investments Ltd
SGX:B73
|
SG |
|
I
|
IQVIA Holdings Inc
F:QTS
|
US |
|
G
|
General Dynamics Corp
F:GDX
|
US |
|
S
|
Shangri-La Asia Ltd
SGX:S07
|
HK |
|
Grindrod Ltd
OTC:GRDLF
|
ZA |
|
Compagnie Financiere Richemont SA
SIX:CFR
|
CH |
|
Grifols SA
F:OZTA
|
ES |
|
A
|
Alexco Resource Corp
XBER:J6W
|
CA |
|
P
|
Publicis Groupe SA
XMUN:PU4
|
FR |
|
Singapore Post Ltd
SGX:S08
|
SG |
|
M
|
Medpal AI PLC
LSE:MPAL
|
UK |
|
A
|
Anglo American Platinum Ltd
SWB:RPH1
|
ZA |
|
S
|
Sahakol Equipment PCL
SET:SQ
|
TH |
|
Occidental Petroleum Corp
BMV:OXY1
|
US |
Bankruptcy Probability
NovaBay Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NovaBay Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
28m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
331.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NovaBay Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NovaBay Pharmaceuticals Inc has total debt of 67k USD. This includes both short-term (67k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
